Thrombosis Drug Market, Global Outlook and Forecast 2022-2028

July 2022 | 65 pages | ID: T67366D7CD98EN
Market Monitor Global

Abstracts

Thrombosis is the medical condition of the emergence of clots in the blood vessels of a human body. Thrombosis drugs are used to treat previous clots or prevent the occurrence of new blood clots. Drugs used to treat thrombosis are most commonly known as anticoagulants. Thrombosis treating drugs are of two main types. One comes in a solution form and can be injected with the help of a syringe and another comes as a pill to be taken orally.

This report contains market size and forecasts of Thrombosis Drug in Global, including the following market information:

Global Thrombosis Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Thrombosis Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

P2Y12 Platelet Inhibitor Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Thrombosis Drug include Pfizer, Aspen Pharmacare Holdings Limited, Bayer AG, AstraZeneca plc, Sanofi, Johnson & Johnson, Bristol-Myers Squibb Company, Baxter International Inc. and Boehringer Ingelheim GmbH and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Thrombosis Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Thrombosis Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Thrombosis Drug Market Segment Percentages, by Type, 2021 (%)

• P2Y12 Platelet Inhibitor
• Xa Inhibitor
• Heparin

Global Thrombosis Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Thrombosis Drug Market Segment Percentages, by Application, 2021 (%)

• Deep Vein Thrombosis
• Pulmonary Embolism
• Atrial Fibrillation

Global Thrombosis Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Thrombosis Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Thrombosis Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Thrombosis Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Aspen Pharmacare Holdings Limited
• Bayer AG
• AstraZeneca plc
• Sanofi
• Johnson & Johnson
• Bristol-Myers Squibb Company
• Baxter International Inc.
• Boehringer Ingelheim GmbH
• GlaxoSmithKline plc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Thrombosis Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Thrombosis Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL THROMBOSIS DRUG OVERALL MARKET SIZE

2.1 Global Thrombosis Drug Market Size: 2021 VS 2028
2.2 Global Thrombosis Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Thrombosis Drug Players in Global Market
3.2 Top Global Thrombosis Drug Companies Ranked by Revenue
3.3 Global Thrombosis Drug Revenue by Companies
3.4 Top 3 and Top 5 Thrombosis Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Thrombosis Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Thrombosis Drug Players in Global Market
  3.6.1 List of Global Tier 1 Thrombosis Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Thrombosis Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Thrombosis Drug Market Size Markets, 2021 & 2028
  4.1.2 P2Y12 Platelet Inhibitor
  4.1.3 Xa Inhibitor
  4.1.4 Heparin
4.2 By Type - Global Thrombosis Drug Revenue & Forecasts
  4.2.1 By Type - Global Thrombosis Drug Revenue, 2017-2022
  4.2.2 By Type - Global Thrombosis Drug Revenue, 2023-2028
  4.2.3 By Type - Global Thrombosis Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Thrombosis Drug Market Size, 2021 & 2028
  5.1.2 Deep Vein Thrombosis
  5.1.3 Pulmonary Embolism
  5.1.4 Atrial Fibrillation
5.2 By Application - Global Thrombosis Drug Revenue & Forecasts
  5.2.1 By Application - Global Thrombosis Drug Revenue, 2017-2022
  5.2.2 By Application - Global Thrombosis Drug Revenue, 2023-2028
  5.2.3 By Application - Global Thrombosis Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Thrombosis Drug Market Size, 2021 & 2028
6.2 By Region - Global Thrombosis Drug Revenue & Forecasts
  6.2.1 By Region - Global Thrombosis Drug Revenue, 2017-2022
  6.2.2 By Region - Global Thrombosis Drug Revenue, 2023-2028
  6.2.3 By Region - Global Thrombosis Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Thrombosis Drug Revenue, 2017-2028
  6.3.2 US Thrombosis Drug Market Size, 2017-2028
  6.3.3 Canada Thrombosis Drug Market Size, 2017-2028
  6.3.4 Mexico Thrombosis Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Thrombosis Drug Revenue, 2017-2028
  6.4.2 Germany Thrombosis Drug Market Size, 2017-2028
  6.4.3 France Thrombosis Drug Market Size, 2017-2028
  6.4.4 U.K. Thrombosis Drug Market Size, 2017-2028
  6.4.5 Italy Thrombosis Drug Market Size, 2017-2028
  6.4.6 Russia Thrombosis Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Thrombosis Drug Market Size, 2017-2028
  6.4.8 Benelux Thrombosis Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Thrombosis Drug Revenue, 2017-2028
  6.5.2 China Thrombosis Drug Market Size, 2017-2028
  6.5.3 Japan Thrombosis Drug Market Size, 2017-2028
  6.5.4 South Korea Thrombosis Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Thrombosis Drug Market Size, 2017-2028
  6.5.6 India Thrombosis Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Thrombosis Drug Revenue, 2017-2028
  6.6.2 Brazil Thrombosis Drug Market Size, 2017-2028
  6.6.3 Argentina Thrombosis Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Thrombosis Drug Revenue, 2017-2028
  6.7.2 Turkey Thrombosis Drug Market Size, 2017-2028
  6.7.3 Israel Thrombosis Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Thrombosis Drug Market Size, 2017-2028
  6.7.5 UAE Thrombosis Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Thrombosis Drug Major Product Offerings
  7.1.4 Pfizer Thrombosis Drug Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Aspen Pharmacare Holdings Limited
  7.2.1 Aspen Pharmacare Holdings Limited Corporate Summary
  7.2.2 Aspen Pharmacare Holdings Limited Business Overview
  7.2.3 Aspen Pharmacare Holdings Limited Thrombosis Drug Major Product Offerings
  7.2.4 Aspen Pharmacare Holdings Limited Thrombosis Drug Revenue in Global Market (2017-2022)
  7.2.5 Aspen Pharmacare Holdings Limited Key News
7.3 Bayer AG
  7.3.1 Bayer AG Corporate Summary
  7.3.2 Bayer AG Business Overview
  7.3.3 Bayer AG Thrombosis Drug Major Product Offerings
  7.3.4 Bayer AG Thrombosis Drug Revenue in Global Market (2017-2022)
  7.3.5 Bayer AG Key News
7.4 AstraZeneca plc
  7.4.1 AstraZeneca plc Corporate Summary
  7.4.2 AstraZeneca plc Business Overview
  7.4.3 AstraZeneca plc Thrombosis Drug Major Product Offerings
  7.4.4 AstraZeneca plc Thrombosis Drug Revenue in Global Market (2017-2022)
  7.4.5 AstraZeneca plc Key News
7.5 Sanofi
  7.5.1 Sanofi Corporate Summary
  7.5.2 Sanofi Business Overview
  7.5.3 Sanofi Thrombosis Drug Major Product Offerings
  7.5.4 Sanofi Thrombosis Drug Revenue in Global Market (2017-2022)
  7.5.5 Sanofi Key News
7.6 Johnson & Johnson
  7.6.1 Johnson & Johnson Corporate Summary
  7.6.2 Johnson & Johnson Business Overview
  7.6.3 Johnson & Johnson Thrombosis Drug Major Product Offerings
  7.6.4 Johnson & Johnson Thrombosis Drug Revenue in Global Market (2017-2022)
  7.6.5 Johnson & Johnson Key News
7.7 Bristol-Myers Squibb Company
  7.7.1 Bristol-Myers Squibb Company Corporate Summary
  7.7.2 Bristol-Myers Squibb Company Business Overview
  7.7.3 Bristol-Myers Squibb Company Thrombosis Drug Major Product Offerings
  7.7.4 Bristol-Myers Squibb Company Thrombosis Drug Revenue in Global Market (2017-2022)
  7.7.5 Bristol-Myers Squibb Company Key News
7.8 Baxter International Inc.
  7.8.1 Baxter International Inc. Corporate Summary
  7.8.2 Baxter International Inc. Business Overview
  7.8.3 Baxter International Inc. Thrombosis Drug Major Product Offerings
  7.8.4 Baxter International Inc. Thrombosis Drug Revenue in Global Market (2017-2022)
  7.8.5 Baxter International Inc. Key News
7.9 Boehringer Ingelheim GmbH
  7.9.1 Boehringer Ingelheim GmbH Corporate Summary
  7.9.2 Boehringer Ingelheim GmbH Business Overview
  7.9.3 Boehringer Ingelheim GmbH Thrombosis Drug Major Product Offerings
  7.9.4 Boehringer Ingelheim GmbH Thrombosis Drug Revenue in Global Market (2017-2022)
  7.9.5 Boehringer Ingelheim GmbH Key News
7.10 GlaxoSmithKline plc.
  7.10.1 GlaxoSmithKline plc. Corporate Summary
  7.10.2 GlaxoSmithKline plc. Business Overview
  7.10.3 GlaxoSmithKline plc. Thrombosis Drug Major Product Offerings
  7.10.4 GlaxoSmithKline plc. Thrombosis Drug Revenue in Global Market (2017-2022)
  7.10.5 GlaxoSmithKline plc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Thrombosis Drug Market Opportunities & Trends in Global Market
Table 2. Thrombosis Drug Market Drivers in Global Market
Table 3. Thrombosis Drug Market Restraints in Global Market
Table 4. Key Players of Thrombosis Drug in Global Market
Table 5. Top Thrombosis Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Thrombosis Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Thrombosis Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Thrombosis Drug Product Type
Table 9. List of Global Tier 1 Thrombosis Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Thrombosis Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Thrombosis Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Thrombosis Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Thrombosis Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Thrombosis Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Thrombosis Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Thrombosis Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Thrombosis Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Thrombosis Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Thrombosis Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Thrombosis Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Thrombosis Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Thrombosis Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Thrombosis Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Thrombosis Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Thrombosis Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Thrombosis Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Thrombosis Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Thrombosis Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Thrombosis Drug Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Thrombosis Drug Product Offerings
Table 32. Pfizer Thrombosis Drug Revenue (US$, Mn), (2017-2022)
Table 33. Aspen Pharmacare Holdings Limited Corporate Summary
Table 34. Aspen Pharmacare Holdings Limited Thrombosis Drug Product Offerings
Table 35. Aspen Pharmacare Holdings Limited Thrombosis Drug Revenue (US$, Mn), (2017-2022)
Table 36. Bayer AG Corporate Summary
Table 37. Bayer AG Thrombosis Drug Product Offerings
Table 38. Bayer AG Thrombosis Drug Revenue (US$, Mn), (2017-2022)
Table 39. AstraZeneca plc Corporate Summary
Table 40. AstraZeneca plc Thrombosis Drug Product Offerings
Table 41. AstraZeneca plc Thrombosis Drug Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi Corporate Summary
Table 43. Sanofi Thrombosis Drug Product Offerings
Table 44. Sanofi Thrombosis Drug Revenue (US$, Mn), (2017-2022)
Table 45. Johnson & Johnson Corporate Summary
Table 46. Johnson & Johnson Thrombosis Drug Product Offerings
Table 47. Johnson & Johnson Thrombosis Drug Revenue (US$, Mn), (2017-2022)
Table 48. Bristol-Myers Squibb Company Corporate Summary
Table 49. Bristol-Myers Squibb Company Thrombosis Drug Product Offerings
Table 50. Bristol-Myers Squibb Company Thrombosis Drug Revenue (US$, Mn), (2017-2022)
Table 51. Baxter International Inc. Corporate Summary
Table 52. Baxter International Inc. Thrombosis Drug Product Offerings
Table 53. Baxter International Inc. Thrombosis Drug Revenue (US$, Mn), (2017-2022)
Table 54. Boehringer Ingelheim GmbH Corporate Summary
Table 55. Boehringer Ingelheim GmbH Thrombosis Drug Product Offerings
Table 56. Boehringer Ingelheim GmbH Thrombosis Drug Revenue (US$, Mn), (2017-2022)
Table 57. GlaxoSmithKline plc. Corporate Summary
Table 58. GlaxoSmithKline plc. Thrombosis Drug Product Offerings
Table 59. GlaxoSmithKline plc. Thrombosis Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Thrombosis Drug Segment by Type in 2021
Figure 2. Thrombosis Drug Segment by Application in 2021
Figure 3. Global Thrombosis Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Thrombosis Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Thrombosis Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Thrombosis Drug Revenue in 2021
Figure 8. By Type - Global Thrombosis Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Thrombosis Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Thrombosis Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Thrombosis Drug Revenue Market Share, 2017-2028
Figure 12. US Thrombosis Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Thrombosis Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Thrombosis Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Thrombosis Drug Revenue Market Share, 2017-2028
Figure 16. Germany Thrombosis Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Thrombosis Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Thrombosis Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Thrombosis Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Thrombosis Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Thrombosis Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Thrombosis Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Thrombosis Drug Revenue Market Share, 2017-2028
Figure 24. China Thrombosis Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Thrombosis Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Thrombosis Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Thrombosis Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Thrombosis Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Thrombosis Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Thrombosis Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Thrombosis Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Thrombosis Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Thrombosis Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Thrombosis Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Thrombosis Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Thrombosis Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Thrombosis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Aspen Pharmacare Holdings Limited Thrombosis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bayer AG Thrombosis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AstraZeneca plc Thrombosis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi Thrombosis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Johnson & Johnson Thrombosis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bristol-Myers Squibb Company Thrombosis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Baxter International Inc. Thrombosis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Boehringer Ingelheim GmbH Thrombosis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. GlaxoSmithKline plc. Thrombosis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)